Mr. Chair, thank you very much for the question.
Again, this is a very important topic for us. I think we are working very hard, as all drug regulators are, to make sure we have the best and the utmost up-to-date scientific information.
As the member noted, in some cases for children, because they obviously have different metabolisms--they're in a different stage of life--there can be a need for specific information. That's why at Health Canada we have established a pediatric expert group to give us information. We've been working with the industry and with other regulators internationally to try to understand what is the best approach and what are the tools we can use to make sure we protect children as best we can.
Those are a number of the things that we are doing to tackle this issue.